Share this
Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes
Web.com to Buy Yodle for $342 Million
Guardant Health Series D Financing
Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
Rovi Corporation Completes $345 Million Convertible Note Offering
Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility
Jazz Pharmaceuticals plc Rule 144A Offering of $575 Million of Exchangeable Senior Notes
Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering
Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05
Brocade in $300 Million 4.625 % Senior Notes Offering